165 related articles for article (PubMed ID: 1174160)
1. Clinical implications of renin in the hypertensive patient.
Brunner HR; Gavras H
JAMA; 1975 Sep; 233(10):1091-3. PubMed ID: 1174160
[No Abstract] [Full Text] [Related]
2. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
Laragh JH; Case DB; Wallace JM; Keim H
Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
[TBL] [Abstract][Full Text] [Related]
3. [Various inhbitors of the renin-angiotensin system and their clinical use].
Bar-Andziak E
Pol Arch Med Wewn; 1979 Jan; 61(1):69-74. PubMed ID: 370806
[No Abstract] [Full Text] [Related]
4. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic and therapeutic significance of inhibitors of the renin-angiotensin system].
Stumpe KO; Kolloch RE; Redlich B; Vetter H; Krück F
Verh Dtsch Ges Kreislaufforsch; 1977; 43():167-76. PubMed ID: 613561
[No Abstract] [Full Text] [Related]
6. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
Brunner HR; Gavras H; Ribeiro AB; Posternak L
Prog Biochem Pharmacol; 1976; 12():145-62. PubMed ID: 1019161
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin blockade in hypertension.
Streeten DH; Anderson GH
Ann Intern Med; 1977 Mar; 86(3):353-4. PubMed ID: 842997
[No Abstract] [Full Text] [Related]
8. A new look at the hypertension problem: the role of the renin system for analysis and treatment.
Laragh JH
Compr Ther; 1985 Oct; 11(10):6-17. PubMed ID: 3902342
[No Abstract] [Full Text] [Related]
9. The effects of angiotensin II blockade in conscious sodium-depleted dogs.
Stephens GA; Davis JO; Freeman RH; Watkins BE; Khosla MC
Endocrinology; 1977 Aug; 101(2):378-8. PubMed ID: 885110
[No Abstract] [Full Text] [Related]
10. [The renin-angiotensin system. Physiopathological aspects and clinical implications of hypertensive syndromes. A survey].
Molinatti GM; Limone P
Minerva Med; 1981 Mar; 72(12):715-32. PubMed ID: 6164019
[TBL] [Abstract][Full Text] [Related]
11. The renin system in essential, renovascular and adrenocortical hypertension: an overview.
Laragh JH
Adv Nephrol Necker Hosp; 1977; 7():157-89. PubMed ID: 96672
[No Abstract] [Full Text] [Related]
12. Physiologic determinants and clinical applications of angiotensin II blockade in hypertensive disorders.
Parra-Carrillo JZ; Baer L; Radichevich I
Cardiovasc Clin; 1978; 9(1):183-95. PubMed ID: 667880
[No Abstract] [Full Text] [Related]
13. Effect of saralasin on plasma aldosterone in hypertensive man.
Brown RD; Tucker R; Tue K; Wisgerhof M; Salassa R
J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
[No Abstract] [Full Text] [Related]
14. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.
Case DB; Wallace JM; Keim HJ; Sealey JE; Laragh JH
Am J Med; 1976 May; 60(6):825-36. PubMed ID: 1020762
[TBL] [Abstract][Full Text] [Related]
15. Editorial: Mechanisms in hypertension.
Lancet; 1975 Sep; 2(7932):445. PubMed ID: 51247
[No Abstract] [Full Text] [Related]
16. [Angiotensin II inhibitors for the diagnosis and treatment of hypertension].
Brunner HR; Gavras H
Schweiz Med Wochenschr; 1976 Dec; 106(50):1791-8. PubMed ID: 1013701
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function.
Atlas SA; Niarchos AP; Case DB
Am J Nephrol; 1983; 3(2-3):118-27. PubMed ID: 6191567
[No Abstract] [Full Text] [Related]
18. The second Volhard Lecture: The use of blocking agents to define the functions of the renin--angiotensin system.
Davis JO
Clin Sci Mol Med Suppl; 1975 Jun; 2():3s-14s. PubMed ID: 802643
[No Abstract] [Full Text] [Related]
19. The use of saralasin to evaluate the function of the brain renin-angiotensin system.
Reid IA
Prog Biochem Pharmacol; 1976; 12():117-34. PubMed ID: 1019160
[TBL] [Abstract][Full Text] [Related]
20. The immediate pressor response to saralasin: a measure of the degree of angiotensin II vascular receptor vacancy.
Wallace JM; Case DB; Laragh JH; Sealey JE; Keim HJ; Drayer JI
Trans Assoc Am Physicians; 1977; 90():300-12. PubMed ID: 205983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
